Literature DB >> 27871958

Current Perspectives on Stem Cell Therapy for Erectile Dysfunction.

Taylor C Peak1, James Anaissie1, Wayne J G Hellstrom2.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) is a common sexual disorder that affects the lives of millions of male patients and their partners. Various medical and surgical therapies exist, with the most common being oral intake of phosphodiesterase 5 inhibitors. One therapeutic strategy in preclinical development to treat ED is stem cell transplantation. AIM: To examine the studies that have investigated stem cells for the treatment of ED.
METHODS: A literature review was performed through PubMed focusing on stem cells and ED. MAIN OUTCOME MEASURES: An assessment of different types of stem cells and how they may be applied therapeutically in the treatment of ED.
RESULTS: The stem cell types that have been investigated for the treatment of ED include bone marrow-derived mesenchymal, adipose-derived, muscle-derived, testes, urine-derived, neural crest, and endothelial progenitor. Depending on the cell type, research has demonstrated that with transplantation, stem cells exert a paracrine effect on penile tissue, and can differentiate into smooth muscle, endothelium, and neurons.
CONCLUSION: Multiple stem cell lines are currently being studied for their potential to treat ED. To date, stem cells have proven safe and effective in both animal and human models of ED. More research is needed to understand their full therapeutic potential.
Copyright © 2016 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erectile Dysfunction; Penile Tissue; Stem Cell Therapy

Mesh:

Year:  2016        PMID: 27871958     DOI: 10.1016/j.sxmr.2016.02.003

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  8 in total

Review 1.  Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis.

Authors:  Ahmed Mohamed Hassanin; Ahmed Zain Abdel-Hamid
Journal:  Int Urol Nephrol       Date:  2019-10-15       Impact factor: 2.370

Review 2.  Neuroprotective and Nerve Regenerative Approaches for Treatment of Erectile Dysfunction after Cavernous Nerve Injury.

Authors:  Jeffrey D Campbell; Arthur L Burnett
Journal:  Int J Mol Sci       Date:  2017-08-18       Impact factor: 5.923

3.  Pharmacological Advances in the Management of Sexual Dysfunction.

Authors:  M S Reddy; M Starlin Vijay
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

Review 4.  Adipose Tissue-Derived Stem Cell Therapy for Cavernous Nerve Injury-Induced Erectile Dysfunction in the Rat Model: A Systematic Review and Meta-Analysis Using Methodological Quality Assessment.

Authors:  Hyo Jung Park; Hyunsuk Jeong; Yong Hyun Park; Hyeon Woo Yim; U-Syn Ha; Sung-Hoo Hong; Sae Woong Kim; Na Jin Kim; Ji Youl Lee
Journal:  Int J Stem Cells       Date:  2019-07-31       Impact factor: 2.500

Review 5.  Cavernous Nerve Injury Resulted Erectile Dysfunction and Regeneration.

Authors:  Nan Jiang; Cheng Wu; Xunrong Zhou; Guanghua Zhai; Jian Wu
Journal:  J Immunol Res       Date:  2021-12-21       Impact factor: 4.818

6.  An EPO-loaded multifunctional hydrogel synergizing with adipose-derived stem cells restores neurogenic erectile function via enhancing nerve regeneration and penile rehabilitation.

Authors:  Jun Shao; Pan Nie; Wende Yang; Rui Guo; Dongbing Ding; Rongpu Liang; Bo Wei; Hongbo Wei
Journal:  Bioeng Transl Med       Date:  2022-05-31

7.  Co-overexpression of VEGF and GDNF in adipose-derived stem cells optimizes therapeutic effect in neurogenic erectile dysfunction model.

Authors:  Wende Yang; Zehong Chen; Xiaolei Ma; Xi Ouyang; Jiafeng Fang; Hongbo Wei
Journal:  Cell Prolif       Date:  2020-01-13       Impact factor: 6.831

8.  Extracorporeal shock wave therapy combined with engineered mesenchymal stem cells expressing stromal cell-derived factor-1 can improve erectile dysfunction in streptozotocin-induced diabetic rats.

Authors:  Dongho Shin; Seung Hwan Jeon; Wen Jie Tian; Eun Bi Kwon; Ga Eun Kim; Woong Jin Bae; Hyuk Jin Cho; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim
Journal:  Transl Androl Urol       Date:  2021-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.